REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 171 filers reported holding REGENXBIO INC in Q4 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $45,490 | -15.9% | 2,764 | +2.2% | 0.00% | – |
| Q2 2023 | $54,061 | -2.0% | 2,705 | -7.3% | 0.00% | – |
| Q1 2023 | $55,150 | -61.7% | 2,917 | -53.9% | 0.00% | – |
| Q4 2022 | $143,870 | -13.9% | 6,324 | +0.0% | 0.00% | – |
| Q3 2022 | $167,000 | +13.6% | 6,322 | +5.4% | 0.00% | – |
| Q2 2022 | $147,000 | -31.6% | 5,998 | -7.6% | 0.00% | – |
| Q1 2022 | $215,000 | +5.4% | 6,491 | +3.7% | 0.00% | – |
| Q4 2021 | $204,000 | -8.5% | 6,262 | +17.5% | 0.00% | – |
| Q3 2021 | $223,000 | -65.1% | 5,328 | -67.6% | 0.00% | -100.0% |
| Q2 2021 | $639,000 | +23.1% | 16,444 | +8.0% | 0.00% | 0.0% |
| Q1 2021 | $519,000 | +79.0% | 15,227 | +138.7% | 0.00% | 0.0% |
| Q4 2020 | $290,000 | +544.4% | 6,378 | +295.7% | 0.00% | – |
| Q3 2020 | $45,000 | -8.2% | 1,612 | +22.2% | 0.00% | – |
| Q2 2020 | $49,000 | +2.1% | 1,319 | -9.7% | 0.00% | – |
| Q1 2020 | $48,000 | – | 1,461 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 1,459,128 | $110,164,000 | 6.60% |
| ArchPoint Investors | 224,187 | $16,926,000 | 4.60% |
| Redmile Group, LLC | 1,656,065 | $125,033,000 | 3.85% |
| WS MANAGEMENT LLLP | 954,812 | $72,088,000 | 2.37% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 342,000 | $25,821,000 | 1.19% |
| Perceptive Advisors | 470,672 | $35,536,000 | 0.95% |
| Pier Capital, LLC | 94,492 | $7,134,000 | 0.90% |
| Ipswich Investment Management Co., Inc. | 29,932 | $2,260,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 275,000 | $20,763,000 | 0.74% |
| Timpani Capital Management LLC | 27,835 | $2,102,000 | 0.61% |